John Snisarenko

Insider Reports History

Location
Alpharetta, GA
Signature
/s/ John Snisarenko
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by John Snisarenko:

Form 4 holding Chief Commercial Officer

Oyster Point Pharma, Inc.

Security class
Common Stock
Shares / value
30,322
Estimated value
$339,606
Report date
09 Jan 2022
Price
$11.20
Ownership
Direct
Form 4 holding Director

ALIMERA SCIENCES INC

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Sep 2024
Price
$3.83
Ownership
Direct
Form 4 holding Chief Commercial Officer

Oyster Point Pharma, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
54,500
Estimated value
Report date
09 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALIMERA SCIENCES INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Snisarenko

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .